We are live on ! Find out more
EPIM

Evelyn Partners Investment Management Portfolio holdings

AUM $3.68B
1-Year Est. Return 21.15%
This Fund
S&P 500
This Quarter Est. Return
-2.13%
1 Year Est. Return
+21.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3B
AUM Growth
-$78.3M
Cap. Flow
+$33M
Cap. Flow %
1.1%
Top 10 Hldgs %
45.98%
Holding
435
New
19
Increased
74
Reduced
120
Closed
15

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$6.07M
2
JPM icon
JPMorgan Chase
JPM
+$5.57M
3
AMZN icon
Amazon
AMZN
+$5.1M
4
UNH icon
UnitedHealth
UNH
+$4.97M
5
TSM icon
TSMC
TSM
+$4.69M

Top Sells

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$5.71M
2
BUR icon
Burford Capital
BUR
+$2.71M
3
AAPL icon
Apple
AAPL
+$2.7M
4
V icon
Visa
V
+$2.69M
5
GS icon
Goldman Sachs
GS
+$2.53M

Sector Composition

Rank Sector Weight
1 Financials 21.55%
2 Technology 20.08%
3 Healthcare 14.71%
4 Consumer Discretionary 14.59%
5 Communication Services 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WBD icon
376
Warner Bros
WBD
$69.3B
$4.35K ﹤0.01%
405
-113
-22% -$1.18K
ARQT icon
377
Arcutis Biotherapeutics
ARQT
$3.3B
$4.22K ﹤0.01%
270
ADNT icon
378
Adient
ADNT
$1.44B
$4.03K ﹤0.01%
313
CDZI icon
379
Cadiz
CDZI
$292M
$4K ﹤0.01%
1,366
MAT icon
380
Mattel
MAT
$4.19B
$3.89K ﹤0.01%
200
ALB icon
381
Albemarle
ALB
$15.1B
$3.82K ﹤0.01%
53
BYND icon
382
Beyond Meat
BYND
$214M
$3.76K ﹤0.01%
1,001
-3,425
-77% -$12.6K
FBIN icon
383
Fortune Brands Innovations
FBIN
$5.83B
$3.65K ﹤0.01%
60
APLS
384
DELISTED
Apellis Pharmaceuticals
APLS
$3.28K ﹤0.01%
150
KLG
385
DELISTED
WK Kellogg Co
KLG
$2.83K ﹤0.01%
142
CC icon
386
Chemours
CC
$2.29B
$2.57K ﹤0.01%
190
-64
-25% -$1.06K
TAK icon
387
Takeda Pharmaceutical
TAK
$55.6B
$2.48K ﹤0.01%
167
PRTA icon
388
Prothena Corp
PRTA
$475M
$2.46K ﹤0.01%
199
SOLV icon
389
Solventum
SOLV
$14.5B
$2.43K ﹤0.01%
32
-31
-49% -$2.31K
GRAL
390
GRAIL Inc
GRAL
$3.08B
$2.09K ﹤0.01%
82
-12
-13% -$371
NOK icon
391
Nokia
NOK
$57.6B
$1.94K ﹤0.01%
368
JAZZ icon
392
Jazz Pharmaceuticals
JAZZ
$16.2B
$1.86K ﹤0.01%
15
QS icon
393
QuantumScape Corp
QS
$3.92B
$1.66K ﹤0.01%
+400
New +$1.98K
EMBC icon
394
Embecta
EMBC
$269M
$1.45K ﹤0.01%
114
EDIT icon
395
Editas Medicine
EDIT
$436M
$1.39K ﹤0.01%
1,200
-750
-38% -$1.1K
NAK
396
Northern Dynasty Minerals
NAK
$953M
$1.35K ﹤0.01%
1,200
BEEM icon
397
Beam Global
BEEM
$25.8M
$1.22K ﹤0.01%
+600
New +$1.55K
VOO icon
398
Vanguard S&P 500 ETF
VOO
$1.03T
$1.03K ﹤0.01%
2
CEVA icon
399
CEVA Inc
CEVA
$857M
$948 ﹤0.01%
37
UI icon
400
Ubiquiti
UI
$35B
$930 ﹤0.01%
3
-4
-57% -$1.41K

Similar funds

Evelyn Partners Investment Management's Q1 2025 Portfolio in Review

As of Q1 2025, Evelyn Partners Investment Management held 435 positions worth $3B, down 2.5% from $3.08B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Evelyn Partners Investment Management's Q1 2025 filing shows 19 new, 74 increased, 120 reduced and 15 closed positions. Its largest new stake was International Paper: 79,549 shares worth $4.24M. The largest sale was Becton Dickinson, an estimated $5.71M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

  • Evelyn Partners Investment Management's largest Q1 2025 buy was International Paper: 79,549 shares worth $4.24M.
  • Evelyn Partners Investment Management added most to NVIDIA in Q1 2025, an estimated $6.07M increase.
  • Evelyn Partners Investment Management's biggest Q1 2025 reduction was Becton Dickinson, cutting an estimated $5.71M.
  • Evelyn Partners Investment Management fully exited Realty Income in Q1 2025, selling an estimated $267K.
  • Evelyn Partners Investment Management's ten largest holdings make up 46% of its $3B portfolio in Q1 2025.
  • Evelyn Partners Investment Management opened 19 new positions and closed 15 in Q1 2025.
  • Evelyn Partners Investment Management's portfolio value fell 2.5% quarter-over-quarter to $3B.

Based on Evelyn Partners Investment Management's 13F filing for Q1 2025, filed 4 Aug 2025.